Selventa

About:

Selventa offers scientific consulting services, licensed software products and strategic partnerships for the medical sector.

Website: http://www.selventa.com

Twitter/X: selventa

Top Investors: Flagship Pioneering, A. M. Pappas & Associates

Description:

Selventa, a personalized healthcare company, provides scientific consulting services, licensed software products, and strategic partnerships for pharmaceutical and biotechnology companies and academic institutions globally. It helps partner companies to develop and optimize pharmaceutical portfolios in various disease areas; analyzes patient data; accelerates the development process; and clarifies decisions on therapeutics and diagnostics. The company engages in short-, mid-, and long-term relationships with pharmaceutical and life science companies to develop new therapeutics and mechanistic biomarkers in the areas of oncology, metabolic disorders, cardiovascular diseases, inflammation, and drug safety. Its solutions also include Hypothesis Investigation Suite, which delivers Project Manager and Project Workbench applications for loading and analyzing large volumes of experiment data using an interactive workbench; Model Investigation Suite offers flash-based applications for viewing, analyzing, and creating explanatory biological models. These analytical software tools are offered to academic, pharmaceutical and biotechnology partners through various hosting options. Selventa was formerly known as Genstruct, Inc. and changed its name to Selventa in November 2010. The company was founded in 2002 and is based in Cambridge, Massachusetts.